Clinical Manifestations of Pituitary Disease

Slide 1 · Clinical Manifestations

of Pituitary Disease

Endocrine excess • Hormonal deficiency • Local mass effects • Water balance

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Classify clinical presentations into endocrine excess, deficiency, local effects, and ADH disorders

Explain the hypothalamic–pituitary relationships underlying characteristic syndromes

Link optic chiasm compression and pituitary apoplexy to neurologic findings

Use focused clinical patterns to distinguish common pituitary mechanisms

Slide 3 · Clinical manifestations of pituitary disease

Hormone excess creates characteristic endocrine syndromes

Hormone deficiency produces loss of target-organ functions

Local expansion injures neighboring sellar and suprasellar structures

Posterior-pituitary disorders alter water and electrolyte homeostasis

Slide 4 · Four questions organize clinical presentation

Is there a syndrome of hormone hypersecretion?

Is there clinical evidence of one or more hormone deficiencies?

Is there headache, visual loss, or another local mass effect?

Is the dominant problem polyuria or hyponatremia?

Slide 5 · The sella determines the clinical anatomy

Hypothalamus

Pituitary stalk

Optic chiasm: Immediately superior

Anterior lobe

Posterior

Sella turcica

Clinical implications

Upward growth

Visual-field defect

Anterior destruction

Hormone deficiency

Functional neoplasm

Hormone excess

Hemorrhagic expansion

Acute apoplexy

Slide 6 · Anterior and posterior lobes have distinct roles

Mechanism / finding

Adenohypophysis contains differentiated endocrine cell populations

Anterior hormones regulate growth, gonadal function, thyroid, and adrenal cortex

Clinical implication

Neurohypophysis stores and releases hypothalamic ADH and oxytocin

Distinguishing lobes is essential for interpreting symptoms

Slide 7 · Hypothalamic control precedes anterior pituitary secretion

Releasing factors travel to the anterior lobe through portal vessels

Dopamine inhibits lactotroph secretion of prolactin

Loss of a hypothalamic input can mimic primary pituitary dysfunction

A hypothalamic or stalk lesion may generate mixed endocrine signs

Slide 8 · Hormone phenotype is not equivalent to tumor size

Mechanism / finding

Small functioning tumors may generate conspicuous endocrine symptoms

Clinically silent tumors can enlarge before being detected

Clinical implication

A large lesion may cause hormone loss by compressing normal gland

Endocrine output and local anatomy must be assessed separately

Slide 9 · Clinical phenotypes reflect different causal routes

A secreting tumor can produce a hormone-excess syndrome

Destructive injury or mass compression can cause hypopituitarism

Chiasmal compression causes visual field loss independently of secretion

ADH imbalance produces renal water-handling manifestations

Slide 10 · Hyperpituitarism is a hormone-excess state

Excess trophic hormone secretion usually originates in a functioning PitNET

Hypothalamic dysregulation is an additional, less frequent mechanism

Nonpituitary hormone secretion can imitate a pituitary hypersecretory state

Clinical phenotype depends on the particular hormone affected

Slide 11 · Functional PitNETs produce recognizable syndromes

Lactotroph tumor

Hyperprolactinemia

Somatotroph tumor

GH excess with raised IGF-1

Corticotroph tumor

Excess corticotropin and Cushing disease

Thyrotroph tumor

TSH-mediated hyperthyroidism

Slide 12 · Silent tumors may still express hormones

Mechanism / finding

Immunohistochemical hormone expression does not guarantee a clinical secretory syndrome

Some corticotroph and most gonadotroph tumors can be clinically silent

Clinical implication

Silent lesions frequently present with mass effect or hypopituitarism

A clinical label of “nonfunctioning” is not a histologic lineage diagnosis

Slide 13 · PitNET classification follows cellular lineage

Lineage-associated transcription factors help identify pituitary tumor subtypes

PIT-1/POU1F1-related lineages include GH, PRL, and TSH tumors

TPIT/TBX19 lineage identifies corticotroph differentiation

SF-1 lineage identifies gonadotroph differentiation

Slide 14 · Hyperprolactinemia primarily disrupts reproduction

Amenorrhea and infertility may make hormone excess readily apparent

Galactorrhea may accompany elevated prolactin concentrations

Loss of libido and sexual dysfunction can affect either sex

Presentation reflects hormone physiology rather than just tumor extent

Slide 15 · Prolactin-related symptoms vary by sex and age

Mechanism / finding

Menstrual-cycle disturbance can reveal tumors early in younger women

Males and older women may have less conspicuous hormonal symptoms

Clinical implication

A clinically subtle lesion can enlarge before it is recognized

Large lesions may consequently present with visual or other mass effects

Slide 16 · Dopamine normally restrains prolactin secretion

Hypothalamic dopamine provides tonic inhibition of lactotrophs

Disruption of the stalk reduces this inhibitory input

Prolactin may rise despite absence of a prolactin-secreting tumor

This mechanism underlies the clinically important stalk effect

Slide 17 · Elevated prolactin does not always mean a prolactinoma

Pregnancy and breastfeeding are physiological settings of prolactin elevation

Dopamine receptor antagonism may elevate prolactin

Stalk injury or a suprasellar mass may cause disinhibition

Renal failure and hypothyroidism are other possible causes

Slide 18 · The stalk effect is a diagnostic pitfall

A non-lactotroph sellar tumor can interfere with hypothalamic dopamine

Loss of tonic inhibition produces secondary hyperprolactinemia

A mildly raised prolactin concentration alone does not identify lineage

Interpret biochemistry alongside symptoms and sellar anatomy

Slide 19 · Growth hormone excess acts largely through IGF-1

Somatotroph PitNET

GH secretion

Liver

IGF-1 production

Growing tissues

Growth response

Before epiphyseal closure

Gigantism: Excessive linear growth

After epiphyseal closure

Acromegaly: Soft tissue and acral growth

Slide 20 · Gigantism reflects excess before epiphyseal closure

GH and IGF-1 promote excessive linear growth in children

Long bones can lengthen while growth plates remain open

Marked height and disproportionately long limbs are characteristic

Acromegalic soft-tissue changes may coexist

Slide 21 · Acromegaly reflects excess after epiphyseal closure

Linear growth is no longer possible once growth plates close

Skin, soft tissues, viscera, and selected bones enlarge

Facial coarsening and jaw protrusion are useful clinical clues

The syndrome may evolve slowly and be recognized late

Slide 22 · Acral and craniofacial findings provide diagnostic clues

Mechanism / finding

Hands and feet enlarge, with thickened digits

Mandibular growth causes prognathism and broadens the lower face

Clinical implication

Soft-tissue overgrowth changes facial and extremity contours

Slow progression can conceal the underlying hormone excess

Slide 23 · GH excess has systemic consequences

Impaired glucose tolerance and diabetes may develop

Hypertension, cardiac failure, and skeletal-joint disease may occur

Muscle weakness and gonadal dysfunction are additional manifestations

Clinical burden extends beyond changes in facial appearance

Slide 24 · Biochemistry confirms suspected acromegaly

Raised serum IGF-1 documents the sustained GH effect

Failure to suppress GH after oral glucose supports excess secretion

The relevant pituitary lesion must then be correlated with anatomy

Symptoms alone are insufficient to establish the biochemical disorder

Slide 25 · Corticotroph tumors create an ACTH-excess phenotype

ACTH stimulates the adrenal cortex to produce glucocorticoids

Pituitary ACTH excess is specifically termed Cushing disease

Cushing syndrome has additional pituitary-independent causes

The pituitary origin cannot be assumed from hypercortisolism alone

Slide 26 · Cushing disease is a subtype of Cushing syndrome

Mechanism / finding

Cushing syndrome describes the clinical state of glucocorticoid excess

Cushing disease specifies a pituitary corticotroph source of ACTH

Clinical implication

The distinction is etiologic rather than semantic

Pituitary-directed conclusions require demonstration of the source

Slide 27 · Nelson syndrome combines tumor growth and pigmentation

After bilateral adrenalectomy, glucocorticoid negative feedback is lost

A corticotroph tumor may subsequently expand and cause mass effects

Skin hyperpigmentation can accompany increased POMC-derived peptides

Absence of adrenal glands prevents endogenous hypercortisolism

Slide 28 · Thyrotroph tumors are a rare source of hyperthyroidism

An uncommon TSH-producing PitNET drives the thyroid gland

The hyperthyroid clinical phenotype results from excess thyroid stimulation

Pituitary etiology differs from primary thyroid hyperfunction

Interpretation requires considering the entire feedback axis

Slide 29 · Gonadotroph tumors often present without excess symptoms

Mechanism / finding

Most secrete hormone amounts that do not cause a recognizable syndrome

They are commonly identified through visual or headache symptoms

Clinical implication

Deficiency of gonadal function may accompany normal-gland compression

Immunophenotype and clinical functionality must be distinguished

Slide 30 · The endocrine phenotype localizes the dominant axis

Prolactin excess

Menstrual, fertility, lactation, and sexual disturbances

GH/IGF-1 excess

Somatic overgrowth plus metabolic effects

ACTH excess

A pituitary cause of hypercortisolism

TSH excess

Thyroid hormone–excess manifestations

Slide 31 · Hypopituitarism is failure of pituitary hormonal output

Loss may involve a single anterior pituitary hormone or several

Both pituitary and hypothalamic lesions can cause insufficient secretion

The clinical phenotype depends on which trophic outputs fail

A normal-sized or small lesion does not exclude clinically important loss

Slide 32 · Hypopituitarism often reflects destructive pathology

Sellar masses can compress or replace functional parenchyma

Trauma and subarachnoid hemorrhage can impair secretion

Surgery, radiation, ischemia, and inflammation may damage gland

Recognition depends on connecting deficits to a plausible lesion or event

Slide 33 · A mass can produce hypopituitarism by compression

Enlarging lesions exert pressure on adjacent normal anterior lobe

Reduced functioning tissue lowers one or more hormone outputs

Tumor tissue itself need not hypersecrete hormones

An expanding silent PitNET can cause both deficiency and headache

Slide 34 · Traumatic and vascular injury are important etiologies

Traumatic brain injury can impair hypothalamic or pituitary function

Subarachnoid hemorrhage is another recognized cause

Patterns of hormone loss may not coincide with obvious external injury

The history of neurologic injury should enter endocrine assessment

Slide 35 · Pituitary treatment can damage the normal gland

Surgery may remove some nonneoplastic pituitary parenchyma

Radiation can injure normal hormone-producing tissue

Deficiencies may coexist with treatment of a previously functional tumor

Clinical interpretation requires knowing the treatment history

Slide 36 · Sheehan syndrome is postpartum ischemic necrosis

Pregnancy

Anterior lobe enlarges

Obstetric hemorrhage

Blood perfusion falls

Ischemia

Anterior-lobe infarction

Hormone loss

Lactation failure ± other deficits

Posterior lobe is usually spared because of its direct arterial blood supply.

Slide 37 · Postpartum lactation failure can signal pituitary damage

Prolactin deficiency can impair milk production after delivery

A history of obstetric hemorrhage supports ischemic pituitary injury

Other anterior hormone deficiencies may accompany lactation failure

The key link is postpartum ischemia followed by loss of pituitary output

Slide 38 · An empty sella can have different mechanisms

Mechanism / finding

Primary empty sella follows herniation of meninges and CSF through a diaphragmatic defect

Compression and flattening of the gland may impair function

Clinical implication

Secondary empty sella follows loss or removal of an earlier sellar mass

Imaging appearance alone does not establish the endocrine state

Slide 39 · Rathke cleft cysts can compromise pituitary function

A cyst can accumulate fluid and expand within the sellar region

Expansion displaces normal hormone-producing parenchyma

The mechanism of dysfunction is mass compression rather than secretion

Cystic pathology belongs in the differential of a sellar mass

Slide 40 · Hypothalamic disease may mimic primary pituitary failure

Reduced releasing factors can decrease anterior pituitary secretion

Lesions can also compromise ADH production or delivery

Tumors, radiation injury, inflammatory disorders, and infections are causes

Mixed anterior and posterior deficits suggest broader axis involvement

Slide 41 · Inflammatory and immune injury may reduce hormone output

Sarcoidosis and tuberculous meningitis may affect the hypothalamus

Immune checkpoint therapy can precipitate autoimmune pituitary injury

The clinical consequences reflect the hormonal deficits produced

Pathologic mechanism may be inflammatory rather than neoplastic

Slide 42 · Inherited lineage defects can produce combined deficiency

Developmental transcription factors establish anterior pituitary cell types

POU1F1/PIT-1 defects may impair GH, prolactin, and TSH output

A combination of deficits can indicate shared developmental lineage

These causes are rare compared with acquired destructive disorders

Slide 43 · Growth hormone deficiency changes with age

Mechanism / finding

In children, impaired GH output causes growth failure and short stature

In adults, reduced lean body mass and increased fat mass may occur

Clinical implication

Clinical consequences reflect the normal age-dependent role of GH

Isolated height is not the appropriate adult screening clue

Slide 44 · Gonadotropin deficiency affects reproductive function

Mechanism / finding

Reduced LH and FSH compromise gonadal stimulation

In women, menstrual disruption, amenorrhea, and infertility may follow

Clinical implication

In men, reduced libido, impotence, and androgen-dependent hair loss may occur

The phenotype reflects downstream sex-steroid deficiency

Slide 45 · TSH deficiency causes a central thyroid deficit

Pituitary failure reduces trophic stimulation of the thyroid

Insufficient thyroid output causes hypothyroid manifestations

The relevant abnormality lies upstream of an otherwise responsive gland

Interpret the thyroid phenotype in its pituitary context

Slide 46 · ACTH deficiency can cause adrenal insufficiency

Loss of corticotropin reduces adrenal cortical stimulation

Adrenal insufficiency may contribute to hypotension and systemic illness

Acute loss during pituitary apoplexy can cause circulatory collapse

This deficit makes abrupt pituitary failure especially dangerous

Slide 47 · Prolactin deficiency is distinctive after childbirth

Mechanism / finding

Prolactin supports mammary milk production

Pituitary lactotroph failure may lead to postpartum lactation failure

Clinical implication

Its absence is a deficiency phenotype, unlike galactorrhea in excess

Clinical relevance depends on pregnancy and postpartum context

Slide 48 · Multiple hormone losses create a compound syndrome

Compression, infarction, or inflammation can affect several lineages

Symptoms may combine gonadal, thyroid, adrenal, and growth-related deficits

The dominant complaint need not reveal every missing hormone

Evaluation of an injured pituitary cannot focus on a single axis

Slide 49 · The sellar location links mass size to symptoms

An enlarging lesion may extend superiorly toward the optic chiasm

Compression can disturb vision before other neurological findings occur

Further expansion may produce headache and additional neurologic signs

Hormone secretion and local mass effects are separate dimensions

Slide 50 · Optic chiasm compression causes temporal visual loss

Bitemporal hemianopsia: Outer visual-field loss

Left temporal

Field lost

Nasal field

Preserved

Nasal field

Preserved

Right temporal

Field lost

Optic chiasm: Crossing visual pathways

Sellar mass ↑

Slide 51 · Bitemporal hemianopsia is a localizing clinical pattern

Mechanism / finding

Patients lose the outer visual fields in both eyes

The defect arises from disruption of crossing chiasmal fibers

Clinical implication

A suprasellar component of a sellar lesion should be considered

The precise field pattern depends on anatomical involvement

Slide 52 · Expanding pituitary masses can cause headache

Like other intracranial masses, they may increase intracranial pressure

Headache can accompany nausea and vomiting

These symptoms are less anatomically specific than chiasmal field loss

Clinical severity may reflect compression rather than endocrine function

Slide 53 · Some sellar tumors cause diplopia

Mechanism / finding

Neurologic symptoms can include double vision from ocular motor involvement

This can accompany an expanding lesion or hemorrhagic complication

Clinical implication

Diplopia is distinct from bitemporal visual field loss

Its appearance demands assessment for acute or progressive local effects

Slide 54 · Pituitary apoplexy is acute hemorrhagic expansion

Hemorrhage may occur in a pre-existing pituitary tumor

Sudden enlargement causes abrupt worsening of local compression

Normal pituitary tissue may lose function rapidly

It can be a life-threatening neurosurgical emergency

Slide 55 · Apoplexy combines neurologic and endocrine danger

Sudden severe headache and diplopia may accompany acute enlargement

Acute loss of ACTH may cause adrenal insufficiency and hypotension

Severe presentations include altered consciousness and cardiovascular collapse

The syndrome should not be interpreted as headache alone

Slide 56 · Silent PitNETs may declare themselves late

A hormonally silent lesion lacks an early conspicuous endocrine signature

Continued growth may produce visual symptoms or headache

Compression of adjacent anterior lobe causes hormone deficiencies

A single lesion can therefore present with mass effect and hypopituitarism

Slide 57 · Endocrine signs and mass effects may coexist

A functioning tumor can secrete hormone while also enlarging

A nonfunctioning tumor can compress the pituitary and chiasm

Apoplexy can convert a chronic mass into acute hormone failure

The clinical assessment must integrate all three presentations

Slide 58 · Posterior-pituitary disorders center on ADH

ADH is synthesized in hypothalamic neurons

The posterior lobe stores and releases transported ADH

ADH restricts urinary free-water loss during dehydration

Too little or too much activity disrupts water and sodium balance

Slide 59 · Physiologic ADH release responds to body fluids

High plasma osmolality stimulates ADH secretion

Low circulating pressure or volume also favors ADH release

Increased atrial distention inhibits ADH release

The normal response conserves water when needed

Slide 60 · Central diabetes insipidus reflects AVP deficiency

ADH deficiency is also termed arginine vasopressin deficiency (AVP-D)

The kidney cannot conserve water appropriately when ADH signal is lacking

High volumes of dilute urine are produced

The major clinical risks arise from ongoing free-water loss

Slide 61 · AVP deficiency produces thirst and polyuria

Urine output is increased and urine is relatively dilute

Free-water loss provokes thirst and compensatory polydipsia

Serum sodium and osmolality may rise if losses are not replaced

Access to water strongly modifies clinical severity

Slide 62 · Restricted water access raises dehydration risk

Mechanism / finding

Alert patients can often replace losses by drinking water

Obtunded or bedridden patients may not access adequate water

Clinical implication

Unreplaced free-water loss can cause dangerous dehydration

The same physiological defect may have different clinical severity

Slide 63 · Central and nephrogenic diabetes insipidus differ

Mechanism / finding

Central diabetes insipidus = insufficient AVP production or release

Nephrogenic diabetes insipidus = renal resistance to circulating AVP

Clinical implication

Both produce large volumes of dilute urine and thirst

The primary defect is different despite a shared clinical presentation

Slide 64 · SIADH is excess water retention from ADH

Inappropriate ADH activity increases renal free-water reabsorption

Retained water dilutes serum sodium concentration

Neurologic manifestations relate to hyponatremia and cerebral edema

Peripheral edema is generally absent despite increased body water

Slide 65 · SIADH often originates outside the pituitary

Ectopic ADH from malignant tumors is a major cause

Small-cell lung carcinoma is a classic neoplastic example

Drugs and CNS disorders can also provoke ADH excess

An ADH phenotype does not automatically localize disease to the sella

Slide 66 · The neurologic phenotype of SIADH reflects hyponatremia

Water retention lowers plasma sodium concentration

Reduced extracellular tonicity promotes cerebral water accumulation

Neurologic dysfunction may arise from cerebral edema

The clinical risk differs fundamentally from water-loss disorders

Slide 67 · AVP deficiency and SIADH are opposite water states

Arginine vasopressin deficiency

Insufficient ADH signal

Reduced renal water reabsorption

Large volumes of dilute urine

Thirst; Hypernatremia if water lost

Inappropriate ADH secretion

Excess ADH activity

Excess renal free-water retention

Dilutional hyponatremia

Cerebral edema; Neurologic signs

Slide 68 · Case: Amenorrhea and galactorrhea

A reproductive-age patient develops menstrual cessation and galactorrhea

The phenotype directs attention to prolactin excess

A lactotroph PitNET is one possibility, not the only cause

Exclude physiological, medication, stalk, thyroid, and renal explanations

Slide 69 · Case: Progressive enlargement of hands and jaw

An adult reports larger shoe size and progressive prognathism

The phenotype suggests acquired GH/IGF-1 excess

A raised IGF-1 and failure of GH suppression support acromegaly

A somatotroph PitNET is an important pituitary cause

Slide 70 · Case: Postpartum hemorrhage and failed lactation

After severe obstetric bleeding, milk production is absent

Postpartum ischemic necrosis of the anterior pituitary is a concern

Other trophic hormone deficits may accompany prolactin loss

The chronology distinguishes this from hyperprolactinemic galactorrhea

Slide 71 · Case: Headache with bilateral temporal field loss

Visual field testing reveals reduced temporal fields in both eyes

The pattern localizes to the optic chiasm

An expanding sellar mass may also impair anterior pituitary secretion

Neurologic localization and endocrine characterization are both necessary

Slide 72 · Case: Sudden headache, diplopia, hypotension

Abrupt deterioration can reflect hemorrhage into a pituitary lesion

Acute compression explains headache and ocular symptoms

ACTH loss may produce adrenal insufficiency and hypotension

The constellation warrants recognition as pituitary apoplexy

Slide 73 · A concise clinical classification

Endocrine hyperfunction: Symptoms of the overproduced hormone

Endocrine hypofunction: Impaired target-organ or reproductive function

Local mass effects: Visual, headache, cranial nerve, or acute apoplexy signs

Posterior disorders: Changes in urine concentration and sodium balance

Slide 74 · Integrate localization with physiology

A bitemporal field defect implicates chiasmal compression

A postpartum deficit suggests vascular anterior-pituitary injury

Polyuria with thirst suggests AVP deficiency or resistance

Hyponatremic neurologic dysfunction suggests excess ADH activity

Slide 75 · Essential diagnostic distinctions

Mechanism / finding

Hyperprolactinemia ≠ necessarily a prolactin-secreting PitNET

Cushing disease ≠ all forms of Cushing syndrome

Clinical implication

Clinically nonfunctioning ≠ negative for lineage-marker expression

Central diabetes insipidus ≠ renal vasopressin resistance

Slide 76 · Clinicopathologic conclusions

Hormone excess and loss are mechanistically different but may coexist

Anatomic compression explains the characteristic optic-chiasm phenotype

Acute hemorrhage can rapidly combine neurologic and endocrine failure

ADH dysregulation produces opposite fluid-balance syndromes

Slide 77 · Principal reference and source boundaries

Robbins, Cotran & Kumar: Pathologic Basis of Disease

11th edition (2026), Chapter 24 — The Endocrine System

Primary heading: Clinical Manifestations of Pituitary Disease, p. 972

Supporting context: pituitary anatomy and related syndromes, pp. 971–978

Illustrations in this lecture are original editable explanatory schematics.